The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review
Open accessAbstract
Purpose To determine the accuracy of biochemical tests for the diagnosis of pheochromocytoma and paraganglioma.Methods A search of the PubMed database was conducted for English-language articles published between October 1958 and December 2016 on the biochemical diagnosis of pheochromocytoma and paraganglioma using immunoassay methods or high-performance liquid chromatography with coulometric/electrochemical or tandem mass spectrometric detection for measurement of fractionated metanephrines in 24-h urine collections or plasma-free metanephrines obtained under seated or supine blood sampling conditions.Results Application of the Standards for Reporting of Diagnostic Studies Accuracy Group criteria yielded 23 suitable articles. Summary receiver operating characteristic analysis revealed sensitivities/specificities of 94/93% and 91/93% for measurement of plasma-free metanephrines and urinary fractionated metanephrines using high-performance liquid chromatography or immunoassay methods, respectively. Partial areas under the curve were 0.947 vs. 0.911. Irrespective of the analytical method, sensitivity was significantly higher for supine compared with seated sampling, 95 vs. 89% (p < 0.02), while specificity was significantly higher for supine sampling compared with 24-h urine, 95 vs. 90% (p < 0.03). Partial areas under the curve were 0.942, 0.913, and 0.932 for supine sampling, seated sampling, and urine. Test accuracy increased linearly from 90 to 93% for 24-h urine at prevalence rates of 0.0-1.0, decreased linearly from 94 to 89% for seated sampling and was constant at 95% for supine conditions.Conclusions Current tests for the biochemical diagnosis of pheochromocytoma and paraganglioma show excellent diagnostic accuracy. Supine sampling conditions and measurement of plasma-free metanephrines using high-performance liquid chromatography with coulometric/electrochemical or tandem mass spectrometric detection provides the highest accuracy at all prevalence rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma free or 24-hour urine fractionated metanephrines are recommended as the screening test of choice for pheochromocytoma with a sensitivity of 90% to 95% (202, 203).”
From Adrenal incidentaloma (2020) · cites this paper as [202]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
The Threshold Approach to Clinical Decision Making
Pauker, S. G., & Kassirer, J. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005153022003 · Cited by 1,371
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
OMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562
Sawka, A. M., Jaeschke, R., Singh, R. J., & Young, W. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021251 · Cited by 503
Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results
Eisenhofer, G., Goldstein, D. S., Walther, M. M., Friberg, P., Lenders, J. W. M., Keiser, H. R., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030005 · Cited by 492
Anderson, G. H., Blakeman, N., & Streeten, D. H. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199405000-00015 · Cited by 403
Occurrence of Pheochromocytoma in Rochester, Minnesota, 1950 Through 1979
Beard, A. M., Sheps, S. G., Kurland, L. T., CARNEY, J. A., & Lie, J. T. (1983) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18873-3 · Cited by 403
Eisenhofer, G., Lenders, J. W., Timmers, H., Mannelli, M., Grebe, S. K., Hofbauer, L. C., Bornstein, S. R., Tiebel, O., Adams, K., Bratslavsky, G., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.153320 · Cited by 290
Self-citationA Survey on Adrenal Incidentaloma in Italy1
Mantero, F., Terzolo, M., Arnaldi, G., Osella, G., Masini, A. M., Alı̀, A., Giovagnetti, M., Opocher, G., & Angeli, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6372 · Cited by 285
Interpreting diagnostic accuracy studies for patient care
Mallett, S., Halligan, S., Thompson, M., Collins, P. G. S., & Altman, D. G. (2012) · BMJ · doi:10.1136/bmj.e3999 · Cited by 249
Secondary Hypertension in a Blood Pressure Clinic
Sinclair, A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370070103015 · Cited by 243
Determination of metanephrines in plasma by liquid chromatography with electrochemical detection
Lenders, J. W. M., Eisenhofer, G., Armando, I., Keiser, H. R., Goldstein, D. S., & Kopin, I. J. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.1.97 · Cited by 220
Pheochromocytoma in Sweden 1958–1981
Stenström, G., & Svardsudd, K. F. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02755.x · Cited by 214
Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data.
Stenström, G., & Svardsudd, K. F. (1986) · PubMed · Cited by 212
Hypertension in Pheochromocytoma: Characteristics and Treatment
Zuber, S. M., Kantorovich, V., & Pacák, K. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.02.002 · Cited by 204
Diagnostic Efficacy of Unconjugated Plasma Metanephrines for the Detection of Pheochromocytoma
Raber, W., Raffesberg, W., Bischof, M. G., Scheuba, C., Niederle, B., Gasic, S., Waldhäusl, W. K., & Roden, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.19.2957 · Cited by 180
de Jong, W. H. A., Eisenhofer, G., Post, W. J., Muskiet, F. A. J., de Vries, E. G. E., & Kema, I. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0303 · Cited by 150
Därr, R., Pamporaki, C., Peitzsch, M., Miehle, K., Prejbisz, A., Pęczkowska, M., Weismann, D., Beuschlein, F., Sinnott, R., Bornstein, S. R., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12327 · Cited by 122
Peaston, R., Graham, K. S., Chambers, E. E., van der Molen, J. C., & Ball, S. L. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.012 · Cited by 120
Boyle, J. G., Davidson, D. F., Perry, C. G., & Connell, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2668 · Cited by 120
Is Supine Rest Necessary before Blood Sampling for Plasma Metanephrines?
Lenders, J. W. M., Willemsen, J. J., Eisenhofer, G., Ross, H. A., Pacák, K., Timmers, H. J. L. M., & Sweep, F. C. G. J. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.076489 · Cited by 120
Perry, C. G., Sawka, A. M., Singh, R., Thabane, L., Bajnárek, J., & Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02805.x · Cited by 111
Hickman, P. E., Leong, M., Chang, J., Wilson, S. R., & McWhinney, B. C. (2009) · Pathology · doi:10.1080/00313020802579284 · Cited by 109
The Protean Manifestations of Pheochromocytoma
Manger, W. M. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1128139 · Cited by 107
Grouzmann, E., Drouard-Troalen, L., Baudin, É., Plouin, P., Müller-Stich, B. P., Grand, D., & Buclin, T. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0996 · Cited by 105
Sawka, A. M., Prebtani, A. P. H., Thabane, L., Gafni, A., Levine, M., & Young, W. F. (2004) · BMC Endocrine Disorders · doi:10.1186/1472-6823-4-2 · Cited by 104
Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
Alrezk, R., Suárez, A., Tena, I., & Pacák, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00515 · Cited by 102
Pheochromocytoma as an Endocrine Emergency
Brouwers, F. M., Lenders, J. W. M., Eisenhofer, G., & Pacák, K. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1022981801344 · Cited by 98
Pheochromocytoma – update on disease management
Därr, R., Lenders, J. W. M., Hofbauer, L. C., Naumann, B., Bornstein, S. R., & Eisenhofer, G. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437356 · Cited by 91
Pheochromocytoma: Clinical Observations from a Brooklyn Tertiary Hospital
Ariton, M., JUAN, C. S., & AvRuskin, T. W. (2000) · Endocrine Practice · doi:10.4158/ep.6.3.249 · Cited by 79
Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients
Václavík, J., Stejskal, D., Lačňák, B., Lazárová, M., Jedelský, L., Kadalová, L., Janošová, M., Fryšák, Z., & Vlček, P. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32813aeb5a · Cited by 68
Weismann, D., Peitzsch, M., Raida, A., Prejbisz, A., Gosk-Przybyłek, M., Riester, A., Willenberg, H. S., Klemm, R., Manz, G., Deutschbein, T., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0730 · Cited by 64
Free or Total Metanephrines for Diagnosis of Pheochromocytoma: What Is the Difference?
Eisenhofer, G. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.6.988 · Cited by 60
The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma
Sawka, A. M., Gafni, A., Thabane, L., & Young, W. F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031127 · Cited by 59
Brain, K. L., Kay, J. D., & Shine, B. S. F. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.070805 · Cited by 46
Davidson, D. F. (2002) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456320203900603 · Cited by 46
Procopiou, M., Finney, H., Akker, S. A., Chew, S. L., Drake, W. M., Burrin, J. M., & Grossman, A. B. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0172 · Cited by 43
Sarathi, V., Pandit, R., Patil, V. K., Lia, A. R., Bandgar, T., & Shah, N. S. (2012) · Endocrine Practice · doi:10.4158/ep12050.or · Cited by 43
Impact of LC-MS/MS on the laboratory diagnosis of catecholamine-producing tumors
Eisenhofer, G., Peitzsch, M., & McWhinney, B. C. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.01.027 · Cited by 43
Giovanella, L., Squin, N., Ghelfo, A., & Ceriani, L. (2006) · PubMed · Cited by 40
Pilot quality assurance programme for plasma metanephrines
Pillai, D. N., & Callen, S. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009153 · Cited by 38
Mullins, F., O’Shea, P. M., FitzGerald, R., & Tormey, W. P. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.742 · Cited by 36
Unger, N., Hinrichs, J., Deutschbein, T., Schmidt, H., Walz, M. K., Mann, K., & Petersenn, S. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1309007 · Cited by 36
Radioimmunoassay of free plasma metanephrines for the diagnosis of catecholamine-producing tumors
Pussard, E., Chaouch, A., & Said, T. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0406 · Cited by 35
Kim, H. J., Lee, J. I., Cho, Y. Y., Lee, S., Kim, H. J., Jung, B. C., Kim, S. W., Chung, J. H., Min, Y., Lee, M., et al. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0384 · Cited by 34
Christensen, T. T., Frystyk, J., & Poulsen, P. L. (2011) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.622410 · Cited by 31
Gao, Y., Lu, H., Luo, Q., Chen, L., Ding, Y., & Zhu, R. (2008) · Clinical and Experimental Medicine · doi:10.1007/s10238-008-0162-2 · Cited by 27
Sarathi, V., Pandit, R., Jagtap, V. S., Lila, A. R., Bandgar, T., Menon, P. S., Varthakavi, P., Raghavan, V. P., & Shah, N. S. (2011) · Endocrine Practice · doi:10.4158/ep11058.or · Cited by 26
Proficiency test of plasma free and total metanephrines: report from a study group
Pillai, D. N., Ross, H. A., Kratzsch, J., Pedrosa, W., Kema, I. P., Hoad, K., Rouaix, N., Fathi, M., Nader, H., Mathian, B., et al. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.162 · Cited by 21
Die Diagnose des Phäochromozytoms und Paraganglioms
Därr, R., Lenders, J. W. M., Stange, K., Kindel, B., Hofbauer, L. C., Bornstein, S. R., & Eisenhofer, G. (2013) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0032-1327395 · Cited by 14
Tanaka, Y., Isobe, K., Ma, E., Imai, T., Kikumori, T., Matsuda, T., Maeda, Y., Sakurai, A., Midorikawa, S., Hataya, Y., et al. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0277 · Cited by 13
The role of urinary fractionated metanephrines in the diagnosis of phaeochromocytoma.
Jeyaraman, K., Natarajan, V., Thomas, N., Jacob, P. M., Nair, A., Shanthly, N., Oommen, R., Varghese, G., Joseph, F. J., Seshadri, M. S., et al. (2013) · Europe PMC (PubMed Central) · Cited by 10
Research works printed but not linked: 2
- W.M. Manger, R.W. Gifford, Clinical and Experimental Pheochromocytoma, 2nd ed. (Blackwell Science, Cambridge, MA, 1996)
- P.M. Bossuyt, J.B. Reitsma, D.E. Bruns, C.A. Gatsonis, P.P. Glasziou, L.M. Irwig, D. Moher, D. Rennie, H.C. de Vet, J.G. Lijmer; Standards for Reporting of Diagnostic, A., The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem. 49(1), 7–18 (2003) · DOI · Paper page
Cited by
Sorted by citations
Lenders, J. W. M., Kerstens, M. N., Amar, L., Prejbisz, A., Robledo, M., Taïeb, D., Pacák, K., Crona, J., Zelinka, T., Mannelli, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002438 · Cited by 415
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“For 24-hour urine estimation, the use of acidified containers (to achieve urine pH <4) and storage in a cold place is recommended; measurement of creatinine is often used to ensure adequate collection (108,202,211).”
BackgroundMethodApproach to the Patient With Adrenal Incidentaloma
Bancos, I., & Prete, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab512 · Cited by 201
Eisenhofer, G., Prejbisz, A., Peitzsch, M., Pamporaki, C., Masjkur, J., Rogowski-Lehmann, N., Langton, K., Tsourdi, E., Pęczkowska, M., Fliedner, S., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.291369 · Cited by 181
Self-citationGarcía‐Carbonero, R., Teresa, F. M., Mercader-Cidoncha, E., Mitjavila, M., Robledo, M., Tena, I., Álvarez-Escolá, C., Arístegui, M., Bella-Cueto, M. R., Albiach, C. F., et al. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02622-9 · Cited by 188
Metadata
- Authors
- Därr, R., Kuhn, M., Bode, C., Bornstein, S. R., Pacak, K., Lenders, J. W. M., & Eisenhofer, G.
- Affiliations
- University of Freiburg (DE)
- University Hospital Carl Gustav Carus (DE)
- Radboud University Medical Center (NL)
- Corresponding author
- Därr, Roland
- Venue
- Endocrine
- Published
- 2017-04-12
- Volume
- 56
- Issue
- 3
- Pages
- 495-503
- ISSN
- 0969-711X (ISSN-L)
- 1355-008X
- 1559-0100
- PMC
- PMC6297899
- OpenAlex
- W2607207406
- Cited by
- 105
- References
- 60
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 11 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 13 · 2019: 13 · 2018: 12 · 2017: 2
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Endocrine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (DE) (DA 1630/2-1)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Oncology › Neuroblastoma Research and Treatments
- Keywords
- pheochromocytoma, paraganglioma, metanephrine, plasma free metanephrines, 24-hour urine collection, diagnostic accuracy, immunoassay, HPLC, tandem mass spectrometry, biochemical diagnosis
- MeSH terms
- Adrenal Gland Neoplasms, Chromatography, High Pressure Liquid, Humans, Metanephrine, Paraganglioma, Pheochromocytoma, Sensitivity and Specificity, Specimen Handling, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
